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Introduction
Multiple sclerosis (MS) is the most frequent demy-
elinating disease of the central nervous system 
(CNS) with an active inflammatory and immune 
component.1,2 MS is widely accepted as an autoim-
mune disease, but the aetiology and pathogenic 
mechanisms remain unclear. Current knowledge 
supports that MS develops in genetically susceptible 
individuals as a result of an autoimmune attack to 
the myelin sheath activated through environmental 
factors.3 In MS, activated CD4+ T cells enter the 
CNS and trigger an inflammatory cascade that leads 
to recruitment of other immune cells such as B, 
CD8+ T cells and macrophages and induces the pro-
duction of cytokines, antibodies and complement 
factors.
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Abstract
Background: Recent findings have shown a correlation between the intrathecal IgG index and variants at 
the immunoglobulin heavy chain (IGHC) locus in patients with multiple sclerosis (MS).
Objectives: The objective of this paper is to analyse the association of the locus with MS susceptibility 
and its relationship with intrathecal immunoglobulin (Ig) parameters.
Methods: We genotyped the rs11621145 variant, located at the IGHC locus, in 2726 patients with MS 
and 2133 healthy controls. Associations of intrathecal IgG and IgM indexes with rs11621145 were anal-
ysed by linear regression analysis in 538 MS patients.
Results: We found that rs11621145 showed statistically significant evidence for association with sus-
ceptibility to MS (odds ratio = 0.69, p = 1.053E-09), though validation of this result in additional cohorts 
would be desirable. We confirmed the association between the IgG index and the rs11621145 (p = 6.85E-
07, Beta = 0.207). Furthermore, rs11621145 was inversely correlated with IgM index (p = 7.24E-04, Beta 
= -0.277), and therefore marks a decreased likelihood of presenting IgM oligoclonal bands (odds ratio = 
0.38, p = 2.35E-06).
Conclusions: Our results suggest that the polymorphism of the IGHC locus could be altering the switch-
ing of the Ig isotype in B cells and it may be interfering with T-dependent and T-independent antibody 
responses.
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The role of cerebrospinal fluid (CSF)-resident B cells 
seems to be important in CNS inflammation, but their 
contribution to MS evolution and progression is less 
clear.4 Nonetheless, antigen-directed affinity matura-
tion and terminal differentiation of B cells contribut-
ing to IgG secretion and IgG oligoclonal bands 
(OCBs) occurs within perivascular infiltrates and 
meningeal lymphoid-like follicles in the CNS.5,6
An elevation of intrathecal IgG synthesis and the pres-
ence of OCBs, characteristics of MS,7 further suggest 
the autoimmune origin of lesions in MS. In fact, about 
95% of patients with MS show IgG-OCBs, and close 
to 40% show IgM OCBs in CSF.8,9 Moreover, it has 
been reported that intrathecal IgM synthesis predicts a 
worse disease course in the first stages of MS.10 
Analysis of the IgG index, which is elevated in about 
70% of patients, as well as the presence of OCBs11,12 
have been proposed as complementary data for the 
diagnosis of MS.13
Buck et al.14 have recently reported that genetic vari-
ants in the immunoglobulin heavy chain (IGHC) 
locus are associated with the IgG index in MS, and 
that specific haplotypes might affect intrathecal IgG 
synthesis.
We aimed to study the genetic association as well as 
exploring the immunoglobulin (Ig) profile and OCBs 
in a cohort of Spanish patients with MS. Part of this 
cohort was included in a recent genome-wide associa-
tion (GWA) study.15 Here, we recruited additional 
patients from the same study site and from two other 
Spanish centres, attaining 2726 MS patients and 2133 
sex- and age-matched controls. In this work, we 
investigate the association with MS of single nucleo-
tide polymorphisms (SNPs) within the IGHC locus 
and their relationship with the intrathecal IgG and 
IgM synthesis, as well as with the presence of OCBs 
for both Igs. In addition to confirming the findings of 
Buck et al.14 regarding the association of the IGHC 
locus with the IgG index, we observed that the 
selected variant was associated with both MS suscep-
tibility and IgM status.
Patients and methods
Patients
Patients with suspicion of MS undergo lumbar punc-
ture as part of the diagnostic procedure. Diagnosis 
was made by a neurologists based on McDonald crite-
ria.16 After diagnosis patients were classified as clini-
cally isolated syndrome (CIS), clinically definite MS, 
or non-MS patients. The study cohort from Hospital 
Universitario Virgen Macarena (Sevilla) consisted of 
362 patients with MS, and 414 patients free of MS or 
any other inflammatory disease (i.e. suffering mainly 
from headaches, hydrocephalus, Alzheimer’s disease, 
Parkinson, behavioural changes, and stroke). The 
cohort from Hospital Ramón y Cajal (Madrid) con-
sisted of 179 MS patients. Main features of the 
patients are shown in Table 1. Patients provided 
informed consent for lumbar puncture.
The entire cohort for rs11621145 genotyping study 
comprised 2726 patients with MS meeting established 
diagnostic criteria16 and 2133 healthy controls (mostly 
blood donors and staff). All patients and healthy con-
trols had Caucasian origin. Patients and controls were 
recruited from six different Spanish hospitals: Sevilla 
cohort consisting of 988 cases and 1070 controls from 
Hospital Virgen Macarena, Hospital Virgen de la 
Nieves and Blood Bank of Andalucía; Málaga cohort 
consisting of 647 cases and 402 controls from Hospital 
Carlos Haya; Madrid cohort consisting of 1091 cases 
and 661 controls from Hospital Clínico San Carlos 
and Hospital Ramón y Cajal. Patients provided 
informed consent for blood extraction. The institu-
tional ethics committees of these centres approved the 
study.
Samples and OCB studies
CSF samples were obtained by lumbar puncture from 
patients under suspicion of MS. The study of OCBs 
was performed in laboratories from Hospital 
Universitario Virgen Macarena (Seville) and Ramón y 
Cajal (Madrid). The procedure included the two-step 
detection of OCBs by isoelectric-focusing and incuba-
tion with antibodies to either IgG or IgM.17,18 Ig and 
albumin concentration in CSF and serum were meas-
ured by nephelometry. We quantified intrathecal IgG 
and IgM synthesis as the Ig index (CSF/serum Ig ratio 
divided by the CSF/serum albumin ratio).11 These 
determinations are included in the protocol of routine 
diagnosis for MS in the above-indicated hospitals.
SNP selection and genotyping
SNP selection was based on the SNPs described by 
Buck et al.14 located at chromosome 14, and associ-
ated with IgG index. Linkage disequilibrium and 
Hardy–Weinberg (HW) equilibrium was performed 
with the 1000 Genome Project data for Caucasian pop-
ulations.19 DNA was extracted from peripheral blood 
cells by standard methods using either the Maxwell 
Kit (Promega) or a saline precipitation procedure. The 
SNP rs11621145 was genotyped using Taqman® SNP 
Genotyping Assays (Applied Biosystems) according 
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to the manufacturer’s specifications. Genotyping call 
rates were >95% in each cohort analysed and 10% of 
the samples were genotyped in duplicate with >99% 
concordance.
Statistical analysis
Departure from HW equilibrium was tested using an 
exact test. Genotype data were analysed to obtain 
allele and genotype counts using PLINK V.1.07.20 For 
each available cohort odds ratios (OR), 95% 
Confidence Intervals (CI) and p-value were estimated 
by fitting sex-adjusted logistic regression models with 
PLINK in order to assess the associations between 
rs11621145 and: (a) the MS risk; (b) the presence of 
IgM OCB; and (c) the presence of IgG OCB. Both 
additive and dominant models were explored. In order 
to assess the association between Ig indexes and 
rs11621145, both indexes were transformed using 
natural logarithms as previously done by Buck et al.14 
and, as happened in their study, untransformed data 
did not follow a Gaussian distribution, but was right-
skewed. Once transformed, we analysed both IgG and 
IgM indexes by using the “–linear” command in 
PLINK that fits a linear regression. Thus, for each 
available cohort we obtained sex and age of puncture-
adjusted beta coefficients, 95% CI, and p-values using 
both additive and dominant models. Estimates across 
cohorts were obtained by running meta-analyses for 
each endpoint using the “metan” command in Stata 
12 (College Station, TX, USA). Both random and 
fixed-effects models were used and heterogeneity was 
explored by estimating I2 index and Q statistic.
Results
IgG index associated variant is a risk factor for 
MS
Buck et al.14 reported five SNPs at the Ig locus asso-
ciated with IgG index in MS patients by GWA anal-
ysis. Among these variants, the most associated was 
rs10136766. These polymorphisms present high 
linkage disequilibrium (LD) as determined in 379 
Caucasian individuals included in the 1000 
Genomes Project (r2> 0.49–0.95). However, this 
polymorphism is not in HW equilibrium according 
to the 1000 Genomes Project data. In fact, only the 
second-most associated variant, rs11621145, was 
found in HW equilibrium, and therefore we selected 
this SNP as the best candidate to assess the 
association of this locus with IgG index and MS 
susceptibility.
As shown in Table 2, rs11621145 was genotyped in 
three Spanish cohorts whose controls were in HW 
equilibrium. After logistic regression analyses, we 
found that the dominant model was the one that best 
fitted the data. The rs11621145 was associated to MS 
in all three cohorts, showing a protective effect among 
G allele carriers. The meta-analysis of these results 
along with those from Buck et al.14 for rs11621145 is 
also indicated (Figure 1).
This locus has not been previously associated with 
MS in any of the GWA studies performed so far, but 
the coverage of this locus in the chips used is very 
low.
Table 1. Demographic, clinical characteristics and cerebrospinal fluid parameters of the studied cohorts.
Cohorts Madrid Málaga Sevilla 
 MS Control MS Control MS Control
MS association study  
N 1091 661 647 402 988 1070
Age, mean year 45 48 45 42 42 41
Female (%) 54 66 67.7 67 67 67
PP (%) 4.2 1.4 6.3  
Ig Index study  
N 179 362  
Age, mean year at puncture (range) 37 (13–69) 35 (12–72)  
Females (%) 70 70  
IgG index, geometric mean (range) 1 (0.28–3.77) 0.96 (0.41–6.63)  
IgM index, geometric mean (range) 0.19 (0.02–2.86) 0.17 (0.01–5.53)  
IgG OCB total / + (%) 151/129 (85) 491/456 (93)  
IgM OCB total / + (%) 182/77 (42) 257/112 (44)  
N: number of patients; PP: primary progressive MS; IgG OCB: oligoclonal IgG bands; IgM OCB: oligoclonal IgM bands.
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Figure 1. Forest plots of effect size, additive model, for 
rs11621145 associated with MS risk in the three cohorts 
analysed in the present work and in the cohort from Buck 
et al.14 We estimated the overall effect size using meta-
analysis. The black squares represent the effect estimates 
for the individual cohorts and the horizontal lines represent 
the 95% CIs of the estimates. The diamond represents the 
overall estimate under fixed-effect model.
The G allele frequency of rs11621145 was 0.33 in the 
Spanish population, which is similar to the one found 
among Caucasians in the 1000 Genomes Project (0.39) 
but largely different when compared with other human 
populations (i.e. 0.97 in the African population).
Correlations of rs11621145 with IgG and IgM 
index
We analysed the association between rs11621145* G 
and the natural logarithm of the IgG index and IgM 
index by means of linear regression in the two MS 
cohorts, adjusting for sex and age at puncture (Table 
3). The IgG index was associated with rs11621145 
with a beta coefficient somewhat smaller than the one 
reported by Buck et al.14 but still statistically signifi-
cant. The dominant model, as shown for MS suscepti-
bility, seemed to fit better the data. We found that G 
carriers have higher values of IgG index. Interestingly, 
we found the exact opposite effect on the IgM index: 
the G carriers have a lower IgM index. Thus, G allele 
carriers presented lower MS susceptibility, higher 
intrathecal IgG index, and lower IgM index values.
In order to determine whether the associations found 
between IgG and IgM indexes and the rs11621145 
genotypes were exclusive to MS patients, we per-
formed correlation analysis using 414 CSF samples 
from individuals with non-inflammatory diseases. No 
association was found in these samples (Table 3).
Correlations of rs11621145 with oligoclonal 
IgM bands
Most MS patients enrolled in the present study are 
IgG OCB positives (93% and 85% in Sevilla and 
Madrid cohorts, respectively). We did not observe an 
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association between rs11621145 genotypes and IgG 
OCB. However, the power of this analysis was lim-
ited due to the low number of IgG OCB-negative 
patients, thus we cannot discard this association. On 
the other hand, we did observe an association between 
the presence of IgM OCB and the rs11621145 variant 
in both cohorts available (Sevilla and Madrid) (Table 
4). In this case the additive model seemed to fit better 
the results. The G allele was associated with a lower 
likelihood of presenting IgM OCBs. The G allele was 
associated with protection towards MS, higher IgG 
index, lower IgM index and absence of IgM OCBs.
Discussion
In this work we confirm the previously reported asso-
ciation of the IGHC locus with the intrathecal IgG 
index in MS.14 In addition, we have found that this 
association does not only involve the IgG but also the 
IgM index and IgM OCB. The opposite effects 
observed in the associations between the IgG and IgM 
indexes with the SNP under study, along with the 
localization of this polymorphism in the IGHC gene 
locus, point to an alteration of the equilibrium between 
innate and T-associated immune responses as the 
functional cause of the association.
In the T-cell-mediated immune response, IgM-positive 
B lymphocytes switch to IgG, IgA, or IgE upon immu-
nization or infection.22 This process occurs by a recom-
bination within S regions located upstream of each one 
of the heavy chain constant region (CH) genes resulting 
in a change from IgM expression to one of the down-
stream isotypes. The isotype switching is cytokine-
directed by inducing transcription from promoters 
located upstream to each acceptor S region. Cis-
regulatory elements have been described within the 
IGHC gene locus and participate in the regulation of Ig 
CH gene expression and isotype switch. Different 
knockout experiments have demonstrated the impor-
tance of CH gene transcription for efficient isotype 
switch.23–25 In fact, a human polymorphism in the regu-
latory region located at the 3’ of the IGHC gene locus, 
3’RR enhancer, regulates CH gene transcription.26 This 
Table 3. Association study of the IgG and IgM index from MS and No Inflammatory Disease patients with the rs11621145 SNP by linear 
regression analysis.
Sevilla Madrid Meta-analysis
 N BETA p N BETA p N BETA p
IgG ADD 362 0.147 1.42E–04 176 0.101 0.066 538 0.132 2.52E–05
 DOM 362 0.215 2.6E–05 176 0.187 0.014 538 0.207 6.85E–07
MS  
 IgM ADD 292 –0.219 0.007 173 –0.227 0.013 465 –0.223 2.2E–04
 DOM 292 –0.295 0.0063 173 –0.252 0.048 465 –0.277 7.24E–04
 IgG ADD 414 0.003 0.73  
 DOM 414 0.007 0.57  
No MS  
 IgM ADD 414 0.003 0.73  
 DOM 414 0.0064 0.92  
Sevilla corresponds to samples from the Hospital Virgen Macarena; Madrid corresponds to samples from Hospital Ramón y Cajal of Madrid
N: Number of samples; MS: multiple sclerosis samples; No MS: samples from no inflammatory diseases; BETA: Regression coefficient; p: Asymptotic p-value 
for t-statistic; ADD: additive model; DOM: dominant model.
Table 4. Association between the rs11621145 SNP and the IgM OCB.
Allele N Dominant model p Additive model p 
 OR (95% CI) OR (95% CI)
Sevilla G 255 0.43 (0.26–0.72) 0.0014 0.4937 (0.33–0.75) 0.0008
Madrid G 179 0.32 (0.17–0.6) 0.00038 0.4102 (0.25–0.67) 0.00033
Meta-Analysis 0.3827 2.35E–06 0.4569 1.08E–06
Sevilla corresponds to samples from Hospital Virgen Macarena; Madrid corresponds to samples from Hospital Ramón y Cajal of Madrid.
N: Number of samples; OR: Odds ratio; p: Asymptotic p-value for t-statistic.
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polymorphism associates with selective IgA deficiency 
(IGAD), a common primary immunodeficiency, and 
with IgM concentration.27 Variants in the same 3’RR 
enhancer have been also associated with systemic 
lupus erythematosus.28 In the innate antibody response, 
responsible for the production of more than 80% of 
serum IgM, antibodies are produced against philoge-
netically conserved antigens predominantly of non-
protein nature.29 This antibody response is mainly 
produced by CD5+ B cells and is responsible for 
intrathecal IgM synthesis in MS.30
The polymorphisms associated with IgG index 
reported by Buck et al.14 and validated in this work 
are located in the immunoglobulin gamma heavy 
chain genes (IGHG) region, where four IGHG are 
encoded. However, since we do not know the ultimate 
causal variant of the Ig index alteration, it is not pos-
sible to infer whether the studied variant may be 
affecting cis-regulatory elements located upstream of 
the heavy chain gene modifying expression or whether 
it may be interfering with other process during class 
switching; further study in this area must be per-
formed to clarify the underlying mechanism. It is 
noteworthy that the association between Ig index and 
rs11621145 occurs exclusively among MS patients 
and not in patients with non-inflammatory diseases. 
However, in these control patients, the intrathecal IgG 
would originate from the periphery. It would be 
important to analyse the IgG levels in a group of 
patients with diseases where intrathecal IgG synthesis 
occurs, to determine if the observed effect of the poly-
morphism on the Ig levels is specific to MS. The 
inflammatory environment of the brain in patients 
with MS could be the circumstance that triggers the 
observed effect. Cytokines produced by T helper and 
antigen-presenting cells determine the isotype to 
which B cells will switch, by inducing transcription 
from promoters located upstream to each acceptor S 
region. The promoters for the four IGHG are differen-
tially regulated. They do not respond equally to regu-
latory stimulus, as has been shown by their differential 
response to the deletion of the Ikaros transcription 
factor in an animal model.31 In fact, there are several 
works pointing to the production of specific IgG iso-
types in the CSF of patients MS.32,33 The specific 
cytokine spectrum produced in the brain of the MS 
patient could induce the switch to mainly one of the 
IGHG and this process could be altered by the 
polymorphism.
In this work we showed an association of the Ig locus 
with MS. However, our results were contradictory to 
those previously reported by Buck et al.,14 which 
reported a negative association of the locus with MS. 
Even though in the present study we reached a large 
number of patients and controls from the meta-analy-
sis between Spanish and UK cohorts, we should not 
forget that the small effects of non-HLA loci associ-
ated with MS require very large cohorts to demon-
strate an association with the disease. On the other 
hand, even though all patients and controls were of 
Caucasian origin from Spain, we cannot totally rule 
out that residual population stratification could be 
partially responsible for the disease association 
observed here. For these reasons, it would be desira-
ble for other groups to replicate this association, to 
reach numbers as reported in studies such as the 
Immunochip Project,34 to completely overcome any 
doubts about its involvement in MS susceptibility.
The differences of association observed between 
cohorts were not unexpected, since previous meta-
analyses have reported similar situations.34 However, 
in this case we found notable differences between 
Sevilla and the rest of the cohorts. One clear differ-
ence of this cohort is that almost all patients were IgG 
OCB positive. We believe this could be one of the 
possible reasons for the observed differences in MS 
association between cohorts.
The homozygote individuals for the major allele (A) 
show an increased MS risk. The A allele is also asso-
ciated with higher IgM index, higher IgM OCB and 
lower IgG index. One may think that since A is the 
major allele, the basal function should be associated 
with this allele, and G carriers might have acquired a 
higher ratio of class switching. However, when we 
analysed the allele frequency of rs11621145 in human 
populations other than Europeans, we observed that 
the A allele is almost non-existent in African popula-
tions. Since we do not know the ultimate causal vari-
ant of the effect, we cannot establish whether among 
African populations the rs11621145 polymorphism 
would not capture the functional variant, or that the 
polymorphism causing the effect in the Ig index was 
acquired later in human evolution and conserved in 
non-African populations.
The ultimate reason why these effects on the intrathe-
cal Ig index and IgM bands can contribute to MS risk 
deserves further investigation. However, antibody 
isotype is important for determining the effector anti-
bodies. The CH region is bound by the Fc receptors on 
many cell types. Different CH regions have different 
affinities for these proteins, thus greatly influencing 
antibody function and determining whether antibody–
antigen complexes will activate cells. Pathological 
and clinical studies implicate antibody-dependent 
mechanisms in the immunopathogenesis of MS. 
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Therefore, any effect on the antibody isotype can 
affect MS susceptibility.
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